Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded down 6.1% during trading on Friday . The stock traded as low as C$0.16 and last traded at C$0.16. 15,600 shares changed hands during trading, a decline of 83% from the average session volume of 90,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Down 6.1 %
The stock has a market capitalization of C$24.36 million, a P/E ratio of -5.50 and a beta of 0.39. The stock’s fifty day moving average is C$0.18 and its two-hundred day moving average is C$0.20. The company has a debt-to-equity ratio of 217.41, a current ratio of 0.28 and a quick ratio of 6.67.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Compound Interest and Why It Matters When Investing
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- Short Selling: How to Short a Stock
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
